Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus
- PMID: 36760813
- PMCID: PMC9905712
- DOI: 10.3389/fendo.2022.1085092
Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus
Abstract
Diabetes mellitus is a serious metabolic disorder that can lead to a number of life-threatening complications. Studies have shown that intestinal microbiota is closely related to the development of diabetes, making it a potential target for the treatment of diabetes. In recent years, research on the active ingredients of traditional Chinese medicine (TCM), TCM compounds, and prepared Chinese medicines to regulate intestinal microbiota and improve the symptoms of diabetes mellitus is very extensive. We focus on the research progress of TCM active ingredients, herbal compounds, and prepared Chinese medicines in the treatment of diabetes mellitus in this paper. When diabetes occurs, changes in the abundance and function of the intestinal microbiota disrupt the intestinal environment by disrupting the intestinal barrier and fermentation. TCM and its components can increase the abundance of beneficial bacteria while decreasing the abundance of harmful bacteria, regulate the concentration of microbial metabolites, improve insulin sensitivity, regulate lipid metabolism and blood glucose, and reduce inflammation. TCM can be converted into active substances with pharmacological effects by intestinal microbiota, and these active substances can reverse intestinal microecological disorders and improve diabetes symptoms. This can be used as a reference for diabetes prevention and treatment.
Keywords: active ingredients; diabetes; intestinal microbiota; metabolism; traditional Chinese medicine.
Copyright © 2023 Su, Hu, Tang, Tang and Huang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review.Pharmacol Res. 2020 Jul;157:104824. doi: 10.1016/j.phrs.2020.104824. Epub 2020 Apr 25. Pharmacol Res. 2020. PMID: 32344049 Review.
-
[Interaction of effective ingredients from traditional Chinese medicines with intestinal microbiota].Zhongguo Zhong Yao Za Zhi. 2016 May;41(10):1766-1772. doi: 10.4268/cjcmm20161002. Zhongguo Zhong Yao Za Zhi. 2016. PMID: 28895319 Review. Chinese.
-
An overview of traditional Chinese medicine affecting gut microbiota in obesity.Front Endocrinol (Lausanne). 2023 Mar 1;14:1149751. doi: 10.3389/fendo.2023.1149751. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36936157 Free PMC article. Review.
-
Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.J Ethnopharmacol. 2021 Oct 5;278:114207. doi: 10.1016/j.jep.2021.114207. Epub 2021 May 14. J Ethnopharmacol. 2021. PMID: 34000365 Review.
-
Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota.Biomed Pharmacother. 2021 Jan;133:110857. doi: 10.1016/j.biopha.2020.110857. Epub 2020 Nov 13. Biomed Pharmacother. 2021. PMID: 33197760
Cited by
-
The increased tendency for anemia in traditional Chinese medicine deficient body constitution is associated with the gut microbiome.Front Nutr. 2024 Sep 18;11:1359644. doi: 10.3389/fnut.2024.1359644. eCollection 2024. Front Nutr. 2024. PMID: 39360281 Free PMC article.
-
Environmental endocrine disruptor-induced mitochondrial dysfunction: a potential mechanism underlying diabetes and its complications.Front Endocrinol (Lausanne). 2024 Aug 15;15:1422752. doi: 10.3389/fendo.2024.1422752. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39211449 Free PMC article. Review.
-
Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis.Front Endocrinol (Lausanne). 2024 Jun 5;15:1401648. doi: 10.3389/fendo.2024.1401648. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38899007 Free PMC article.
-
Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review.Front Immunol. 2023 Aug 10;14:1243834. doi: 10.3389/fimmu.2023.1243834. eCollection 2023. Front Immunol. 2023. PMID: 37638043 Free PMC article. Review.
-
Assessment of potential risk factors associated with gestational diabetes mellitus: evidence from a Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Jan 8;14:1276836. doi: 10.3389/fendo.2023.1276836. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260157 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical